Reevaluating ADHD and its First-Line Treatment: Insights from DSM-5-TR and Modern Approaches

Is Attention Deficit Hyperactivity Disorder (ADHD) a “brain disorder”? Should it be managed regularly with stimulant drugs? This article critically examines the evolving biomedical discourse surrounding these questions through a close inspection of the latest edition of the influential psychiatric manual – the DSM-5-TR – as well as additional authoritative sources (e.g., previous DSM editions, consensus statements, FDA communications). The DSM-5-TR acknowledges that “no biological marker is…

via https://pubmed.ncbi.nlm.nih.gov/39540077/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20241127010906&v=2.18.0.post9+e462414